By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
Scientists in Shanghai have achieved a world-first regenerative islet transplant that helps patients with type 1 diabetes regain insulin function. By implementing a new endoderm stem-cell technology, the team has cut the production time of insulin-secreting islet cells from 40 days to just 14 days, which significantly reduces tumor risks. The findings were published in The Lancet Diabetes & Endocrinology.
Scientists in Shanghai have achieved a world-first regenerative islet transplant that helps patients with type 1 diabetes regain insulin function. By implementing a new endoderm stem-cell technology, the team has cut the production time of insulin-secreting islet cells from 40 days to just 14 days, which significantly reduces tumor risks. The findings were published in The Lancet Diabetes & Endocrinology.